You need to upgrade your Flash Player
$0.25 (1.38%)
01:52AM (15 mins delay)
Oct 01, 2009 - 5:15 AM EDT
ChinaBio Today submits: The Anti-Monopoly Bureau of China’s Ministry of Commerce ((MOFCOM)) has given its okay to the merger between Pfizer (NYSE: PFE) and Wyeth (NYSE: WYE). However, MOFCOM will require that Pfizer divest its swine mycoplasmal pneumonia vaccine business. Pfizer has been negotiating with the Anti-Monopoly Bureau on the ruling, implying that it will not be surprised by the ruling, even if it may not agree.
According to the MMLC Group (mmlcgroup.com), the decision from the relatively young Anti-Monopoly Group was short, but very clear in its discussion of administrative law and guidelines. That helps observers in their understanding of how the Anti-Monopoly Group goes about fulfilling its duties. Previous opinions, apparently, left observers wondering how the Group arrived at its conclusions.
Source: Seeking Alpha (Oct 01, 2009 - 5:15 AM EDT)
© 2009 UpDown. All Rights Reserved.
Make a suggestion for this page
Data powered by QuoteMedia (Terms of Use). Data delayed 15 minutes unless otherwise indicated.
